• 1. Alternative donor substrates for inverting and retaining glycosyltransferases?
  Luke L. Lairson,Warren W. Wakarchuk Chem. Commun., 2007, 365-367
• 2. An amorphous Cu–In–S nanoparticle-based precursor ink with improved atom economy for CuInSe2 solar cells with 10.85% efficiency?
  Green Chem., 2017,19, 1268-1277
• 3. An interplay between electronic and structural effects on the photoluminescence decay mechanisms in LaPO4·nH2O:Tb3+ and LaPO4:Tb3+ single-crystal nanorods?
  M. T. Colomer,S. Díaz-Moreno,A. Tamayo,A. L. Ortiz J. Mater. Chem. C, 2018,6, 12643-12651
• 4. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 5. An investigation into the origin of variations in photovoltaic performance using D–D–π–A and D–A–π–A triphenylimidazole dyes with a copper electrolyte?
  Govind Reddy Mol. Syst. Des. Eng., 2021,6, 779-789

Professional Introduction to 2-Chloro-6-methylnicotinoyl Chloride (CAS No. 39853-81-1)

2-Chloro-6-methylnicotinoyl chloride is a specialized chemical compound that has garnered significant attention in the field of pharmaceutical and biochemical research. This compound, identified by its Chemical Abstracts Service (CAS) number 39853-81-1, serves as a crucial intermediate in the synthesis of various pharmacologically active molecules. Its unique structural properties, characterized by a chlorinated nicotinoyl moiety, make it a valuable building block for the development of novel therapeutic agents.

The significance of 2-Chloro-6-methylnicotinoyl chloride in modern drug discovery cannot be overstated. Its molecular structure, which includes a chlorinated pyridine ring and a methyl-substituted nicotinoyl group, provides a versatile platform for chemical modifications. These modifications are essential for tailoring the compound's pharmacokinetic and pharmacodynamic properties, ensuring efficacy and safety in therapeutic applications.

In recent years, there has been a surge in research focused on nicotinamide derivatives due to their broad spectrum of biological activities. 2-Chloro-6-methylnicotinoyl chloride plays a pivotal role in this research landscape by serving as a precursor for synthesizing nicotinamide-based drugs. These drugs have shown promise in treating various conditions, including neurodegenerative diseases, inflammation, and metabolic disorders. The ability to modify the chlorinated nicotinoyl group allows researchers to fine-tune the compound's interactions with biological targets, enhancing its therapeutic potential.

The synthesis of 2-Chloro-6-methylnicotinoyl chloride involves sophisticated organic chemistry techniques that require precise control over reaction conditions. The chlorination step is particularly critical, as it introduces the reactive chloro group that facilitates subsequent chemical transformations. Advanced synthetic methodologies, such as palladium-catalyzed cross-coupling reactions and nucleophilic aromatic substitutions, have been employed to optimize the yield and purity of this intermediate.

The compound's utility extends beyond its role as a synthetic intermediate. It has been investigated for its potential applications in materials science and agrochemicals. The chlorinated pyridine ring can participate in various coordination chemistry reactions, making it useful for developing metal-organic frameworks (MOFs) and other advanced materials. Additionally, its structural motifs are reminiscent of certain agrochemicals, suggesting possible applications in crop protection agents.

Recent studies have highlighted the importance of 2-Chloro-6-methylnicotinoyl chloride in the development of targeted therapies. Researchers have leveraged its structural features to design molecules that selectively interact with specific biological pathways. For instance, derivatives of this compound have been explored as inhibitors of enzymes involved in cancer metabolism. By modulating these pathways, such compounds hold promise for developing more effective cancer treatments with reduced side effects.

The pharmacological profile of derivatives derived from 2-Chloro-6-methylnicotinoyl chloride continues to be an area of active investigation. Preclinical studies have demonstrated that certain nicotinamide-based drugs exhibit potent anti-inflammatory and neuroprotective effects. These findings have spurred further research into identifying new applications for this class of compounds. The structural flexibility offered by the chlorinated nicotinoyl group allows for the creation of diverse analogs with tailored biological activities.

In conclusion, 2-Chloro-6-methylnicotinoyl chloride (CAS No. 39853-81-1) is a multifaceted compound with significant implications in pharmaceutical and biochemical research. Its role as a synthetic intermediate and its potential applications in drug development underscore its importance in modern science. As research continues to uncover new therapeutic possibilities, the demand for high-quality intermediates like this one is expected to grow, driving further innovation in the field.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)